Percutaneous Large Thrombus and Vegetation Evacuation in the Catheterization Laboratory

Interventional Cardiology Clinics(2022)

引用 0|浏览2
暂无评分
摘要
Intracardiac and intravascular thrombi are associated with significant morbidity and mortality. Although surgery remains the gold standard treatment option, these patients often have multiple comorbidities that can make surgical options challenging. With advancements in catheter-based technologies, there are now percutaneous treatment options for these patients. The AngioVac is a percutaneous vacuum-assisted thrombectomy device FDA-approved for removal of intravascular debris that uses a venovenous extracorporeal membranous oxygenation circuit with a filter. Use of this device has now been reported in the removal of right atrial or iliocaval thrombi, debulking tricuspid vegetations, removal of vegetations from implantable cardiac devices, and pulmonary embolism.
更多
查看译文
关键词
AngioVac,Vacuum aspiration thrombectomy,Extracorporeal membrane oxygenation,Tricuspid valve endocarditis,Cardiac implantable electronic devices,Iliocaval thrombus,Right atrial mass
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要